Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Devices
MedTech
Insulet issues voluntary correction for Omnipod devices
Insulet has sent out a voluntary medical device correction notice for a series of its Omnipod devices amid a manufacturing fault.
Ben Adams
May 27, 2026 9:32am
Dexcom warns of stolen glucose monitors being sold
May 27, 2026 7:25am
Olympus pushes deeper into oncology with $270M BioProtect deal
May 26, 2026 3:57pm
Lauxera raises a hefty €520M for health, medtech companies
May 19, 2026 8:00am
Boston Scientific puts $1.5B into MiRus, option to buy its TAVR
May 18, 2026 8:31am
Humacyte cuts spending, staff as it seeks to boost implant sales
May 13, 2026 8:20am
